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Type 1 diabetes is caused by autoimmune destruction of pancreatic beta cells, possibly virus initiated. Virus infection induces
alpha-interferon (IFN-α), leading to upregulation of genes encoding double-stranded (ds) RNA-dependent antiviral enzymes
2 ,5  -oligoadenylate synthetase (2 5 AS) and PKR (p68). To investigate whether beta cell speciﬁcity could be due to antiviral
diﬀerencesbetweenbetaandalphacells,wetreatedbetaandalphaTC3celllineswithIFN-αand/orpoly(I:C)(asyntheticdsRNA).
Results showed that, following IFN-α stimulation, increases in 2 5 AS levels and activities were signiﬁcantly higher in beta than
alpha cells (P<. 001), whereas increases in PKR level and activity were comparable in the two cell types. Poly(I:C) stimulated
2 5 AS activity in beta but not alpha cells, and co-transfection IFN-α plus poly(I:C) induced apoptosis in beta but not alpha cells.
These ﬁndings suggest that the elevated 2 5 AS response of pancreatic beta cells could render them particularly vulnerable to
damage and/or apoptosis during virus infection.
Copyright © 2009 M. Li et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Type 1 diabetes is a common and multifactorial disease
characterized by autoimmune-mediated destruction of the
insulin-producing beta cells of the pancreas. Both genetic
and environmental factors play signiﬁcant roles in the
etiology of type 1 diabetes. Considerable evidence suggests
that enterovirus infection, especially group B coxsack-
ieviruses, is an important environmental factor initiating
or promoting beta cell damage during the development
of type 1 diabetes. A series of prospective Finnish studies
have shown that there is a strong association between
enterovirus infection and beta cell autoimmunity [1–4].
Increased frequencies of serum enterovirus antigens and
antibodies against enterovirus were observed during the
preclinical phase in children who subsequently developed
diabetes [1, 3, 4]. Similarly, it was found that there was
a temporal association between appearance of antiviral
antibodiesandisletcellautoantibodiesinprediabeticsiblings
of type 1 diabetic patients [2, 4]. Furthermore, the ﬁnding
of increased occurrence of intracellular enterovirus-RNA in
peripheral blood lymphocytes (PBL) from type 1 diabetic
children [5] and new evidence of enteroviral infection in
pancreatic islets from deceased patients with type 1 diabetes
[6] strongly suggests the possibility of the involvement of
persistent enterovirus infection in the development of type
1 diabetes.
Virus infections induce the production of type I inter-
ferons (IFN-α/β), which through the IFN receptor-mediated
JAK-STAT signal transduction pathway [7] induce OAS
and PKR genes encoding the key antiviral enzymes 2 5 -
oligoadenylate synthetase (2 5 AS) and proteinkinase p682 Experimental Diabetes Research
(PKR). Both 2 5 AS and PKR are expressed as latent
enzymes, and their enzymatic activities require a cofactor,
double-stranded RNA (dsRNA), an intermediate usually
generated by viral replication in virus infected cells. In
the presence of dsRNA, the activated 2 5 AS polymerizes
ATP into 2 -5 linked oligoadenylates (2 5 A), which in
turn bind and activate a latent endoribonuclease, RNaseL.
Activated RNaseL degrades cellular and viral RNA, thereby
inhibiting protein synthesis [8]. Similarly, PKR, when acti-
vated, homodimerizes and autophosphorylates, leading to
phosphorylation of eukaryotic initiation factor 2 (eIF2) and
inhibition of cellular protein synthesis [9].
Human 2 5 AS comprises a family of at least six enzyme
isoforms, encoded by a cluster of three OAS genes, that is,
OAS1-p42, p44, p46 and p48, OAS2-p69/p71, and OAS3-
p100 [10]. Recently we have described a new splice variant,
adding a new enzyme isoform to this family: OAS1-p52 [11].
We have suggested that processes within the antiviral 2 5 AS
system might contribute to the etiopathogenesis of type 1
diabetes [12]. In several independent studies, we observed
signiﬁcantly increased 2 5 AS activity in patients with type
1 diabetes compared to healthy controls [12, 13]. More
recently, we found a highly signiﬁcant association between
basal 2 5 AS activity and an A/G splice acceptor site single
nucleotide polymorphism (SNP) in the OAS1 gene, indicat-
ing that basal activity of this enzyme is strongly genetically
controlled [11]. We have also reported that the frequencies
of genotypes carrying the genetic variant associated with
elevated activity were signiﬁcantly higher in individuals with
type 1 diabetes than in nondiabetic control subjects [14].
Thus, our original ﬁndings of persistently elevated 2 5 AS
activity in type 1 diabetes patients compared to controls
[12, 13] were at least partly genetically determined. In
other words, elevated 2 5 AS activity might be due to both
genetic and environmental factors. However, it is unclear
how elevated 2 5 AS activity predisposes to the development
of autoimmune type 1 diabetes.
A number of studies have implicated interferon-α (IFN-
α) as a potential mediator of type 1 diabetes pathogenesis.
We have shown 2 5 AS activity to be highly induced by IFN-
α and poly(I:C) (polyinosinic:polycytidylic acid, a synthetic
dsRNA) in insulin-producing RIN rat beta cell lines [15].
Furthermore, we demonstrated that IFN-α sensitivity was
not solely a characteristic of cultured cell lines, since it
was also present in PBL from diabetes-prone BB rats [16]
and in freshly isolated rat islets and rat beta cells [17]. In
human islets, other investigators have shown that IFN-α was
produced de novo by enterovirus-infected beta cells, but not
by enterovirus-infected alpha cells [18]. From those data
and ours, it can be concluded that beta cells not only are
highly responsive to IFN-α and produce signiﬁcant 2 5 AS
activity, but also have the capacity to synthesize IFN-α [18].
It is therefore surprising that despite this highly reactive
antiviral defense system, beta cells display an increased
vulnerability to virus infection [18, 19]. Several studies
have shown presence of IFN-α in human islets, localized
to beta cells, from pancreases of deceased individuals both
with acutely-developing and with long-standing type 1
diabetes [20, 21]. Since IFN-α has a very short half-life,
the persistent presence of this cytokine in the islets could
reﬂect chronic or repeated virus infections and result in
continuous 2 5 AS gene activation. More recent studies have
demonstrated the presence of enteroviruses in human beta
cells of type 1 diabetic patients [6, 22, 23], which provides
direct evidence that speciﬁc viral infection of beta cells
plays an important role in the development of autoimmune
diabetes. dsRNAs are produced during replication of both
D N Aa n dR N Av i r u s e s[ 24]. The viral mimic poly(I:C) is
a synthetic dsRNA that can stimulate immune responses
similar to those observed during virus infections. Recently
it has been shown that the immune response induced
by dsRNA or poly(I:C) is mediated by Toll-like receptors
(TLRs), especially TLR3 [25]. It has also been shown that
poly(I:C) can induce IFN-α production [26, 27], and that
IFN-α induces interferon-stimulated genes (ISGs) including
2 5 AS and PKR [28–30], thus mediating innate immune
responses.
MurinebetaTC3andalphaTC3celllinesaretransgeneti-
cally derived from insulinoma and glucagonoma tumor cells,
and produce insulin and glucagon, respectively, in response
to normal physiologic signals. In the present study, we used
these two cell lines as a model to ask whether functional
diﬀerences between pancreatic beta and alpha cells in their
innate antiviral immune response could explain the beta cell
target speciﬁcity characterizing the autoimmune destruction
seen in type 1 diabetes. More speciﬁcally, we tested the
hypothesis that pancreatic beta and alpha cells diﬀer from
each other in their 2 5 AS and PKR responses and their
sensitivity to apoptosis when stimulated with IFN-α and/or
poly(I:C).
2.MaterialsandMethods
2.1. Reagents. Poly(I:C), (α32P)-ATP, and (γ32P)-ATP were
from AmershamPharmacia. Creatinekinase and creatine
phosphate were purchased from Boehringer-Mannheim
(Mannheim, Germany). DTT, Tris, FCS, penicillin, and
streptomycin were from Invitrogen. Polygram Cel 300
PEI (polyetheleneimine) chromatography plates were from
Machery-Nagel(Duren,Germany).Mouseinterferon-αwere
from R&D Systems. BCA (bicinchoninic acid) and enhanced
ECL kit were from Pierce.
2.2.Cell Culture andStimulation of Cells withIFN-α. Murine
beta TC3 and alpha TC3 cell lines were kindly provided by
Dr.D.Hanahan,UniversityofCalifornia,SanFrancisco.Beta
TC3 cells were maintained in Dulbecco’s modiﬁed Eagles’
medium (DMEM) with 1,000mg/L D-glucose, penicillin
(100U/mL), and streptomycin (100μg/mL) supplemented
with 10% fetal bovine serum (FBS) at 37◦Ci n5 %C O 2
atmosphere. Alpha TC3 cells were cultured in DMEM
medium containing 4,500mg/L D-glucose and 15% FBS. At
near conﬂuency, medium containing the indicated amounts
of IFN-α was added. After 2, 6, 12, and 24 hours of
incubation in the presence or absence of 500U/mL IFN-α,
the cells were trypsinized and prepared for analysis of 2 5 AS
activity.Experimental Diabetes Research 3
2.3. Construction of Mouse IFN-α4a n dT L R 3c D N A s -
Containing Vectors pcDNA3.1-mIFN-α4 and pcDNA3.1-
mTLR3. The whole length of murine IFN-α4 and TLR3
c D N A sw e r ea m p l i ﬁ e db yR T - P C Rf r o mt o t a lR N Ae x t r a c t e d
from beta TC3 cells treated with 500U/mL IFN-α. The PCR
primers were 5 -CTCGAGACCAGCATCTACAAGACCCA-
3  (forward, CTCGAG-XhoI) and 5 -GGATCCTCCACA-
CTTTGTCTCAGGAC-3  (reverse, GGATCC-BamHI) for
mouse IFN-α4 (GenBank accession number X01973)
and 5 -CTCGAGCACCCATAATCTGGGCTGAA-3  (fwd,
CTCGAG-XhoI) and 5 -GGATCCCCCTTTACCGACTCC-
AAATC-3  (rev, GGATCC-BamHI) for mouse TLR3 (Gen-
Bank accession number NM 126166). The ampliﬁed cDNAs
wereinsertedintothemammalianvectors,pcDNA3.1(Invit-
rogen) using the restriction enzyme XhoI and Bam HI sites.
The ﬁnal mIFN-α4a n dm T L R 3c o n s t r u c t sw e r ec o n ﬁ r m e d
by DNA sequencing.
2.4. Transfection of Murine Pancreatic Beta TC3 and Alpha
TC3 Cells. Transient transfection of the pcDNA3.1-mIFN-
α4 and pcDNA3.1-mTLR3 vectors as well as poly(I:C)
into murine pancreatic beta TC3 and alpha TC3 cells was
performed using Lipofectamine 2000 (Invitrogen) according
to manufacturer instructions. The mammalian expression
vector pcDNA3.1 was used as a negative control. For
transfection, 8μg of each of the plasmids and 5μgo f
poly(I:C) were added to 60mm Petri dishes containing
approximately 3 × 106 cells in DMEM supplemented with
10% or 15% FBS. After 24 hours incubation, the transfected
cells were trypsinized and prepared for analysis of 2 5 AS
enzyme activity and Western blots. Transfection eﬃciency
was monitored by including a beta-galactosidase-containing
vector (pcDNA3.1-beta-gal, 0.6μg) during transfection of
betaTC3andalphaTC3cells.Thetransfectioneﬃciencywas
determined by assaying the cell lysates for beta-galactosidase
activity (A405) and by normalizing to total protein (A280).
Transfection eﬃciencies were similar in beta and alpha TC3
cells; there were no signiﬁcant diﬀerences between alpha and
beta cells.
2.5. Immunoblot Analysis. Cell proteins were separated by
12% SDS-PAGE and transferred to nitrocellulose mem-
branes (Sigma). After blocking with 5% bovine serum
albumin for 1 hour, the membranes were incubated with
rabbit polyclonal antibody against recombinant human
2 5 AS protein isolated from infected insect cells using a
Baculovirus expression system. This polyclonal antibody
cross-reacts with murine 2 5 AS, detecting the murine p42
isoform, corresponding to a molecular weight of 42kDa.
For determination of PKR, a polyclonal antibody against
human PKR was used. For detection of cell apoptosis after
treatment with IFN-α and poly(I:C), a polyclonal antibody
againstmousecaspase3(CellSignaling)wasemployed.Blots
were incubated with horseradish-conjugated secondary anti-
bodies followed by enhanced chemiluminescence detection
(Pierce). The blots were scanned and quantitated by use of
theQuantityOne1-DImageanalysissoftware(BioRad).The
% increase in protein expression was assessed by comparing
thedensityofproteinbands,normalizedtothehousekeeping
gene GAPDH.
2.6.Assayof2
 5
 ASandPKREnzymeActivity. 2 5 ASactivity
was determined in lysates of cultured beta TC3 and alpha
TC3 cells as described previously [17]. Trypsinized cells were
washed three times with PBS and lysates were prepared
with 0.5% NP-40. Protein concentration of each cell lysate
was determined with the BCA assay and adjusted to 1.5–
3.0mg/ml before measuring enzyme activity. For assay of
2 5 AS activity, lysates were incubated with 0.15μCi α32P-
ATP for 120 minutes at 30◦C in the presence of 100μg/mL
poly(I:C). The generated 2 5 -oligoadenylates (2 5 A) were
separated by ascending TLC on PEI plates in a Tris buﬀer
(2mM, pH 8.62). Enzyme activity was expressed in units per
milligram protein. One unit of enzyme activity is deﬁned
as nanomoles ATP converted per minute. For assay of
PKR activity, lysates were incubated with 0.15μCi α32P-
ATP for 120 minutes at 30◦C in the presence of 0.1μg/mL
poly(I:C).QuantitationofPKRautophosphorylatingactivity
was performed by 32P-ATP autoradiography.
2.7. Apoptosis Analysis by FACS. For FACS analysis of apop-
tosis,betaTC3andalphaTC3cellsatadensityof3×105/well
(24 well plates) were transiently transfected with 0.8μgo f
pcDNA3.1-mIFN-α4a n d0 . 8 μg of poly(I:C). The empty
plasmid pcDNA3.1 was used as a negative control. After
24 hours incubation, the cell samples were analyzed with
the Annexin-V-PE and 7-AAD staining kit (BD Biosciences)
according to manufacturer instructions. Brieﬂy, medium
was removed from wells and cells were washed in PBS,
trypsinized and spun down. Cell pellets were resuspended in
1 x binding buﬀer at a concentration of 1 × 106/mL. 5μL
of annexin-V-PE, and 7-AAD was added to 100μLo fc e l l
suspension.Themixturewasincubatedatroomtemperature
in the dark for 15 minutes, washed once and FACS buﬀer
wasadded.ThesampleswerethenanalyzedinaFACSCalibur
ﬂow cytometer (BD Biosciences). Twenty thousand cells per
sample were collected.
2.8. Statistical Analysis. All results are presented as mean ±
SD of three independent experiments. Diﬀerences between
groups were examined for statistical signiﬁcance using one-
way analysis of variance (ANOVA). Percentage increases in
protein concentration or enzyme activity after 24 hours
stimulation with IFN-α were calculated relative to non-
stimulated values, with 100% indicating no increase. Values
of P<. 05 were considered to be signiﬁcant.
3. Results
3.1. IFN-α Induced Higher 2
 5
 AS Protein Level and Enzyme
Activity in Beta TC3 than in Alpha TC3 Cells. To determine
whether IFN-α stimulates expression of 2 5 AS, immunoblot
and enzyme assays were performed on lysates of beta and
alpha TC3 cells after 24 hours of IFN-α treatment. As
shown in Figure 1, expressed protein levels and enzyme
activities of 2 5 AS were increased after IFN-α stimulation4 Experimental Diabetes Research
in both beta TC3 and alpha TC3 cells. However, the
increased 2 5 AS protein levels (Figure 1(a))a n de n z y m e
activities (Figure 1(b)) were signiﬁcantly higher in beta than
in alpha TC3 cells. In addition, the increase of 2 5 AS
protein/activity in response to IFN-α stimulation was shown
to be more dose-dependant in beta TC3 cells than in alpha
TC3 cells.
3.2. 2
 5
 AS Activity Was Highly Induced by IFN-α in Beta
TC3 Cells but Not in Alpha TC3 Cells. To further inves-
tigate the increased expression of 2 5 AS following IFN-
α induction, time-course studies were performed. Figure 2
shows the 2 5 AS enzyme activity in lysates of cultured beta
TC3 (Figure 2(a)) and alpha TC3 cells (Figure 2(b)) in the
presenceorabsenceof500U/mlIFN-αfortheindicatedtime
periods.InbetaTC3cells,therewasastrongtime-dependent
increase in 2 5 AS activity in response to IFN-α stimulation,
ranging from 693% to 844% at 24 hours (n = 4) (SD varying
between 6–13% in diﬀerent cell cultures). In alpha TC3 cells,
however, there was a very weak increase in activity, ranging
from 178% to 209% at 24 hours (n = 4). The diﬀerence
between beta and alpha TC3 cells in mean maximal 2 5 AS
activity was statistically highly signiﬁcant (769% compared
to 189%, P<. 001; see summary in Table 1). Constitutive
(non-stimulated) 2 5 AS activity was similar in the two cell
types (Figure 2).
3.3. PKR Protein Level and Enzyme Activity Were Upregulated
Similarly in Beta TC3 and Alpha TC3 Cells. PKR is also an
IFN-α stimulated gene, therefore similar experiments were
performed to determine PKR expression in response to IFN-
α treatment. The expression level of the PKR protein was
determined as the sum of the p68 PKR molecule and the p48
immune reactive degradation product of the PKR molecule,
as previously described [31, 32]( Figure 3). Because PKR
activity is inhibited at higher poly(I:C) concentrations, a
low concentration of 0.1μg/ml was used in all incubations
for the measurement of PKR activity. Figure 3 shows the
u p r e g u l a t i o no fP K Rp r o t e i ni nb e t aT C 3a n da l p h aT C 3
cells in the presence of 500 or 2000U/ml IFN-α.P K Rp r o t e i n
levels were upregulated by 166% and 192%, respectively, in
beta TC3 cells and by 171% and 208% in alpha TC3 cells.
Thus, similar amounts of PKR protein were induced by IFN-
α stimulation of both cell types. Furthermore, the increase
in autophosphorylating activity of PKR after stimulation
with 500 U/ml IFN-α showed no statistically signiﬁcant
diﬀerence between beta TC3 cells (151% ± 13, n = 3)
and alpha TC3 cells (121% ± 19, n = 3) (Figure 4 and
Table 1).
3.4. Poly(I:C) Induced Expression of 2
 5
 AS in Beta TC3 but
Not in Alpha TC3 Cells. Since poly(I:C) is known to be
ap o t e n tI F N - α inducer [26, 27], poly(I:C) was transiently
transfected into beta TC3 and alpha TC3 cells, without or
with mouse IFN-α4 cDNA-containing plasmid, to determine
the eﬀect on expression of 2 5 AS protein. Murine IFN-α4
is an immediate-early interferon and can be produced by
na¨ ıve cells upon viral infection. In order to induce higher
activity of 2 5 AS, we used an IFN-α4-containing plasmid
overexpressing type I IFN in the cell lines to simulate
the situation of cells experiencing acute viral infection. As
shown in Figure 5, introduction of poly(I:C) alone produced
a marked increase in 2 5 AS protein levels (Figure 5(a))
and enzyme activity (Figure 5(b)) in beta TC3 cells, but
not in alpha TC3 cells. Although transfection of mouse
IFN-α4 cDNA resulted in a signiﬁcant increase of 2 5 AS
expression in both beta and alpha TC3 cells, the magnitude
of the increase was much higher in beta than in alpha TC3
cells (Figure 5). However, co-transfection of poly(I:C) and
pcDNA3.1-mIFN-α4 did not result in any further increase of
2 5 ASprotein(Figure 5(a))orenzymeactivity(Figure 5(b))
whencomparedwithmIFN-α4treatmentaloneineitherbeta
TC3 or alpha TC3 cells.
3.5. Induction of 2
 5
 AS by Poly(I:C) in Beta TC3 Cells
Was Not Augmented by TLR3 Overexpression. To investigate
whether TLR3 plays a role in the upregulation of 2 5 AS by
poly(I:C), similar transfection experiments were performed
in beta TC3 and alpha TC3 cells with mouse TLR3 cDNA-
containing vector. Results presented in Figure 6 conﬁrmed
that poly(I:C) alone signiﬁcantly increases 2 5 AS protein
level and enzyme activity in beta TC3 cells, but not in alpha
TC3 cells. In beta TC3 cells, co-transfection of poly(I:C) and
pcDNA3.1-mTLR3 appeared to induce higher expression of
2 5 AS(Figure 6(a)),butnostatisticallysigniﬁcantdiﬀerence
was observed between 2 5 AS activity in the poly(I:C)-
treated only and the co-transfection groups (Figure 6(b)).
In alpha TC3 cells, co-transfection of poly(I:C) and mTLR3
cDNA had no eﬀect on expression of 2 5 AS (Figure 6).
Basal expression of TLR3 mRNA as determined by real-
time RT-PCR was similar in the two cell lines (data not
shown).
3.6. IFN-α and Poly(I:C) Induced Apoptosis in Beta TC3 Cells
but Not in Alpha TC3 Cells. I no r d e rt od e t e r m i n ew h e t h e r
high expression of 2 5 AS induces apoptosis, immunoblot
andﬂowcytometrywereusedtodemonstratethepresenceof
apoptosis in transfected cells. Cleaved caspase 3 was detected
by speciﬁc anti-caspase 3 antibody following transfection of
poly(I:C), mIFN-α4, or both poly(I:C) plus mIFN-α4 into
beta TC3 and alpha TC3 cells. As shown in Figure 7,c o -
transfection of pcDNA3.1-mIFN-α4 and poly(I:C) induced
marked apoptosis, but only in beta TC3 cells. Apoptosis
induction as measured by FACS analysis produced similar
results (Figure 8) to those using immunoblot analysis. Alpha
TC3 cells were resistant to apoptosis; neither stimulation
with poly(I:C), mIFN-α4 nor co-stimulation with poly(I:C)
and mIFN-α4 induced detectable apoptosis as compared
withcontrolcells(Figures8(b)and8(c)).However,betaTC3
cells showed signiﬁcant susceptibility to apoptosis (Figures
8(a) and 8(c)). In these cells, stimulation with poly(I:C)
induced apoptosis in 2.90% more of the treatedcellsthan the
untreated control cells (P<. 05), mIFN-α4 induced 5.87%
more cellular apoptosis (versus controls, P<. 005), and co-
transfectionofbothmIFN-α4andpoly(I:C)induced18.76%
apoptosis (versus controls, P<. 0001).Experimental Diabetes Research 5
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Figure 1: Protein expression and activity of 2 5 AS in non-stimulated and IFN-α stimulated beta TC3 and alpha TC3 cells. After 24 hours
of IFN-α stimulation, cell lysates were prepared. (a) For immunoblot, cell extracts were separated on 12% SDS-PAGE and transferred to
nitrocellulose membranes. The polyclonal antibody speciﬁc to human 2 5 AS (cross-reactive with murine 2 5 AS) was used to detect the
expressed proteins. The polyclonal antibody against mouse GAPDH was used to quantitate the loading amounts; (b) For assay of 2 5 AS
activity, lysates were incubated with 0.15μCi α32P-ATP for 120 minutes at 30◦C in the presence of 100 μg/ml poly(I:C), and then separated
by ascending TLC. The generated 2 5 -oligoadenylates (2 5 A) were quantitated by PhosphorImager analysis. Enzyme activity was expressed
in units per milligram protein (n = 3).
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Figure 2: Enzyme activity of 2 5 AS in non-stimulated and IFN-α stimulated beta TC3 and alpha TC3 cells. Beta TC3 (a) and alpha TC3 (b)
cells were incubated in the presence or absence of 500U/ml of IFN-α. After the indicated time periods, cell lysates were prepared. The lysates
were incubated with 0.15μCi α32P-ATP for 120 minutes at 30◦C in the presence of 100μg/mL poly(I:C), and then separated by ascending
TLC. The generated 2 5 A were quantitated by PhosphorImager analysis. Enzyme activity was expressed in units per milligram (n = 4,
standard deviations varied between 6–13%).
4. Discussion
In the present study, we showed that there is a functional
diﬀerence between mouse pancreatic beta and alpha TC3
cells in 2 5 AS induction in response to IFN-α stimulation.
Firstly, elevations of 2 5 A Sp r o t e i nl e v e la n de n z ym ea c t i vi ty
were signiﬁcantly higher in beta than in alpha TC3 cells
following IFN-α stimulation (Figure 1). Furthermore, only6 Experimental Diabetes Research
Table 1: Summary of mean percentage increases of protein levels and enzyme activities of 2
 5
 AS and PKR in beta TC3 and alpha TC3 cells
after 24 hours 500U/ml of IFN-α stimulation.
2 5 AS (% increase ± SD)∗ PKR (% increase ± SD)∗
Beta TC3 cells (n = 4) Alpha TC3 cells (n = 4) Beta TC3 cells (n = 3) Alpha TC3 cells (n = 3)
Protein 680 ± 70 214 ± 19 166 ± 10 171 ± 12
Activity 769 ± 78 189 ± 15 151 ± 13 121 ± 19
∗100% indicates no change.
0 500 2000 0 500 2000 IFN-α
(U/mL)
βTC3 cells αTC3 cells
p68
p48
Figure 3: Protein expression of PKR in non-stimulated and IFN-
α stimulated beta TC3 and alpha TC3 cells. After beta TC3
and alpha TC3 cells were stimulated with 500U/mL (lane 2
and 5) and 2000U/mL (lane 3 and 6) of IFN-α for 24 hours,
prepared lysates were subjected to 12% SDS-PAGE, transferred
onto nitrocellulose, and immunostained with a polyclonal antibody
speciﬁc for human PKR. Two protein bands were detected; the p48
subunit is the degradation product of PKR (p68). The relative levels
of protein were determined by quantifying the immunoblots using
the Quantity One 1-D Image software (see Table 1).
− + − + − + − + − + − + IFN-α
(500U/mL)
βTC3 cells αTC3 cells
p68
Figure 4: Enzyme activity of PKR in non-stimulated and IFN-α
stimulated beta TC3 and alpha TC3 cells. Beta TC3 and alpha TC3
cells were incubated with or without addition of 500U/mL of IFN-
α into the medium for 24 hours in three independent experiments.
The lysates were subjected to an autophosphorylation assay with
γ32P-ATP. Incubation time was 1 hour. Proteins were fractionated
by 12% SDS-PAGE and radioactive bands were visualized by
autoradiography. After the gels were dried, the protein bands were
cut and the radioactivity was quantitated in a scintillation counter.
beta TC3 cells showed strongly dose- and time-dependant
increases in 2 5 AS enzyme activity after IFN-α treatment
(Figures 1(b) and 2). Secondly, introduction of poly(I:C) (a
synthetic dsRNA) stimulated 2 5 AS expression and activity
in beta TC3 cells but not in alpha TC3 cells (Figures 5 and 6).
Finally, overexpression of IFN-α, with or without poly(I:C),
induces apoptosis in beta TC3 cells but not in alpha TC3 cells
(Figures 7 and 8). It is unlikely that the observed diﬀerences
between pancreatic beta and alpha cells are due to use of
transformed cell lines, since previously we have observed
increased 2 5 AS activity after IFN-α stimulation in primary
rat beta cells but not in rat non-beta (mainly alpha) islet cells
[17]. The results suggest that pancreatic beta cells have much
more intrinsically responsive elements in activation of the
2 5 AS system than alpha cells.
However, no diﬀerence between beta and alpha TC3 cells
wasobservedforinductionofPKR,anotherdsRNAandIFN-
α-dependent antiviral enzyme. The expressed protein level
and enzyme activity of PKR were similarly upregulated in
beta and alpha TC3 cells. In both cell types, p68 and its
p48 degradation product were detected in accordance with
earlier ﬁndings [31, 32]. Expression of PKR has been shown
in mouse, rat, and human islets after dsRNA stimulation and
coxsackievirus infection [33, 34]. Although both 2 5 AS and
PKR are dependent on dsRNA as a cofactor for activation,
it is well known that they diﬀer signiﬁcantly in the dsRNA
concentration needed for activation [9]. PKR is activated
at dsRNA concentrations about 100 times lower than those
needed for 2 5 AS activation, and becomes inhibited at
higher dsRNA concentrations [35]. Thus, at low cellular
dsRNA concentrations PKR-dependent inhibition of protein
synthesis may increase the risk of apoptosis, but at higher
concentrations the 2 5 AS-RNaseL system [36, 37]m a y
promote apoptotic processes. Importantly, we analyzed PKR
activity at very low dsRNA concentrations rather than at
higher inhibitory concentrations, and found similar PKR
activity in beta TC3 and alpha TC3 cells (Figure 4 and
Table 1). This result suggests that if there is a diﬀerence
in antiviral activity-mediated apoptosis between pancreatic
beta and alpha cells, the diﬀerences are not due to PKR-
induced apoptosis.
Although expression and activity of 2 5 AS were similar
after transfection of IFN-α vector alone compared to co-
transfection of IFN-α plus poly(I:C), both in alpha and beta
TC3 cells (Figure 5), we noted that in beta TC3 cells, caspase
3 cleavage and apoptosis were very signiﬁcantly elevated
after IFN-α plus poly(I:C) co-transfection as compared to
IFN-α alone (Figures 7 and 8). At the moment, we do
not know the reason for this discrepancy with respect to
2 5 ASactivityandapoptosis-inductionintheco-transfected
beta TC3 cells. The 2 5 AS enzyme activity in beta cells
appeared to reach maximum biological levels with IFN-
α alone and be nonresponsive to additional stimulus with
poly(I:C), while the apoptotic response of IFN-α-stimulated
beta cells was further augmented by poly(I:C). This could
be due to toxicity of poly(I:C) itself on beta (but not alpha)
cells, although poly(I:C) alone had only a limited eﬀect on
beta cell apoptosis (Figure 8(c)). Alternatively, this could be
due to some other unidentiﬁed pro-apoptotic eﬀect induced
by dsRNA structures, but independent of 2 5 AS enzyme
activity.Interestingly,inhumansithasbeenreportedthattheExperimental Diabetes Research 7
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p48 isoform of 2 5 AS (encoded by the OAS1 gene) has pro-
apoptotic activity independent of its synthetase activity [38],
and that a 2 5 AS-like protein (encoded by the closely-linked
OASL gene)respondstovirusinfectionbuthasnosynthetase
activity [39, 40]. However, the above-noted discrepancy
in the co-transfection experiments does not invalidate the
suggestionthatthehigherIFN-α-stimulated2 5 ASresponse
of beta cells compared to alpha cells (Figures 2 and 5)
contributes to the greater apoptosis observed following IFN-
αtransfectioninbetacellscomparedtoalphacells(Figure 8).
The situation is complex, since poly(I:C) is both a cofactor
for 2 5 AS activation and a potent IFN-α inducer. As shown
in Figure 5,2  5 AS activity in alpha cells was not aﬀected
by poly(I:C) alone, suggesting that poly(I:C) could not
induceIFN-αproductioninalphacells.Thisassumptionwas
consistent with the observation that IFN-α could be detected
in enterovirus-infected beta cells but not in enterovirus-
infected alpha cells [18]. In humans, IFNα induces more
than 40 known IFN-stimulated genes (ISG), among which
dsRNA-dependent antiviral enzymes 2 5 AS and PKR have
beenassociatedwithapoptoticcelldeath.Sincetherewereno
diﬀerences in PKR protein level and enzyme activity between
beta and alpha cells, we propose that the beta cell’s stronger
2 5 AS response to poly(I:C) alone and IFN-α alone (Figures
2 and 5) is a critical contributor to the greater apoptosis seen
in beta compared to alpha pancreatic cells.8 Experimental Diabetes Research
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Figure 7: Induction of apoptosis in beta TC3 and alpha TC3
cells after transfection of IFN-α4-containing vector and poly(I:C).
After beta TC3 and alpha TC3 cells were transiently transfected
with pcDNA3.1-mIFN-α4, poly(I:C), and pcDNA3.1-mIFN-α4
plus poly(I:C) for 24 hours, respectively, induction of apoptosis
was detected by immunoblots. pcDNA3.1 empty vector was used
as a negative control. Cells lysates were separated on 15% SDS-
PAGE and transferred to nitrocellulose membranes. The polyclonal
antibody speciﬁc to mouse caspase 3 was used to detect both the
intact as well as the cleaved caspase 3 proteins.
What are the intrinsic factors in beta cells that contribute
to higher activation of the 2 5 AS system in response to
IFN-α and poly(I:C)? One of the possible contributors is
a characteristic feature of the pancreatic beta cell, that is,
its high rate of insulin synthesis. It is known that during
virus infection, insulin synthesis increases as part of the
stress response. In addition, during development of type
1 diabetes, insulin synthesis increases in an attempt to
reduce high blood glucose levels created by a diminishing
beta cell mass. We have preliminary evidence (described
in what follows) that increased insulin synthesis augments
the eﬀect of IFN-α or poly(I:C) on beta cell 2 5 AS
activity and apoptosis, possibly through the generation of
dsRNA structures during insulin gene transcription. As
mentioned earlier, 2 5 AS is expressed as a latent enzyme
that requires dsRNA (e.g., produced by replicating virus)
to become activated. Binding of dsRNA to 2 5 AS generates
a conformational change in 2 5 AS that is necessary for
enzyme activation [41]. There is now data supporting the
existence of endogenous dsRNA [42]. Furthermore, it has
been show that small single-stranded RNA ligands can also
activate 2 5 AS [43]. Single-stranded mRNA could also play
ar o l ei n2  5 AS activation, since mRNA has been reported
to be a potent endogenous activator of Toll-like receptor
3 (TLR3), likely through secondary dsRNA-like structures
[44]. We have preliminary data showing that beta TC3 cell
apoptosis was signiﬁcantly increased when beta cells were
cultured in high glucose-containing medium (20mmol/L)
compared with low glucose medium (5mmol/L), followed
by treatment with either IFN-α (1000U/mL) or poly(I:C)
(50μg/mL) for 24 hours (Bonnevie-Nielsen et al., unpub-
lished data), suggesting that the higher insulin transcription
rate stimulated by high glucose signiﬁcantly augmented beta
cell sensitivity to apoptosis. Alpha TC3 cells showed little
apoptotic response to any treatment or glucose condition
(note that these results also implied that high glucose per
se does not promote apoptosis). Other preliminary studies
showed that beta cells treated with poly(I:C) for 24 hours
displayed signiﬁcantly higher 2 5 AS activity (approximately
2.5 times higher) when cultured in high glucose compared to
low glucose medium (Bonnevie-Nielsen et al., unpublished
data). Taken together, these ﬁndings suggested that a higher
insulin transcription rate had a strong eﬀect on activation
of 2 5 AS by poly(I:C) and on beta sensitivity to apoptosis
when treated with poly(I:C) or IFN-α. Thus, we hypothesize
that increased insulin gene transcription in beta cells during
virus infection and/or during development of type 1 diabetes
could generate dsRNA-like structures that augment 2 5 AS
activity and contribute to beta cell apoptosis. Consistent
with this hypothesis, it is well established that a genetic
polymorphism (variable number tandem repeat, VNTR)
in the promoter region of the human insulin gene alters
susceptibility to type 1 diabetes, that class I (short-repeat)
VNTR alleles are strongly associated with increased risk of
developingtype1diabetes[45,46],andthatclassIallelesalso
are associated with an increased insulin gene transcription
rate in pancreatic beta cells [47]. Thus, a higher rate of
insulin transcription in persons with class I homozygous
genotypes may genetically predispose them to diabetes by
providing an increased endogenous source of dsRNA-like
molecules that contribute to 2 5 AS activation in beta cells,
particularly during virus infection (Figure 9). Clearly, more
studies are needed to test the “high insulin transcription rate
hypothesis” of beta cell sensitivity to apoptosis.
During viral infection, IFN-α is induced and dsRNAs are
generated. IFN-α stimulates antiviral activity of the innate
immune system through activation of transcription of ISGs
including PKR and 2 5 AS [21, 27, 29, 48]. dsRNA is not
only an essential cofactor for activation of the antiviral
enzymes, but also leads to induction of the antiviral enzymes
either directly or via TLR3-mediated activation of IFN
regulatory factor 3 (IRF-3) and NF-kB signaling pathways
[49]. Although we found that TLR3 did not augment
2 5 AS induction by poly(I:C) in beta TC3 cells (Figure 6),
others have reported that activation of TLR3 by dsRNA
increased beta cell apoptosis via NF-kB and STAT-1 [50].
Thus, dsRNA may contribute to beta cell apoptosis through
multiple pathways. Increased activity of the 2 5 AS-RNaseL
system has been shown to induce apoptosis in several cell
types and is an important mechanism through which virus
replication and spreading is restricted [36, 37]. In addition,
as mentioned earlier, one 2 5 AS isoform can promote
cellular apoptosis independent of synthetase activation of
RNaseL [38]. Although epidemiological and pathological
studies have suggested that enteroviruses are associated with
development of type 1 diabetes, the selective tropism of
these viruses for pancreatic beta cells and the factors that
determine the sensitivity of beta cells to virus infection
are still not well understood. It has been reported that
administration of poly(I:C) accelerated the development of
diabetes in DP-BB rats, and there was a dose-relationship of
poly(I:C) with serum IFN-α levels and the time of onset of
diabetes [51]. IFN-α has been detected in residual pancreatic
islets from deceased patients with recent-onset or long-term
type 1 diabetes [20, 21]a n dI F N - α was reported to be a
potential mediator of type 1 diabetes induced by poly(I:C) in
C57BL/6 mice expressing the B7.1 costimulatory protein inExperimental Diabetes Research 9
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Figure 8: FACS analysis of apoptosis induction in beta TC3 and alpha TC3 cells after transfection of mouse IFN-α4-containing vector
and poly(I:C). Beta TC3 and alpha TC3 cells were transiently transfected with pcDNA3.1-mIFN-α4, poly(I:C), and pcDNA3.1-mIFN-α4
plus poly(I:C), respectively. pcDNA3.1 empty vector was used as a negative control. After 24 hours, the cell samples were stained with the
Annexin-V-PE and 7-AAD kit, and induction of apoptosis was assayed by FACS analysis. (a) Beta TC3 cells; (b) alpha TC3 cells; (c) the
percentage of apoptosis of induction in beta TC3 and alpha TC3 cells after transfection. ∗P<. 05, ∗∗P<. 005, ∗∗∗P<. 0001 (transfected
group versus control, n = 3).
islets [52]. Somewhat paradoxically, it has also been reported
that induction of IFNs in virus-infected beta cells was critical
for their survival during viral infection [18, 53]. Increased
numbers of enteroviral infections have been reported in
prediabetic individuals [2, 4, 54], and recently enteroviruses
have been detected in pancreatic tissue from type 1 diabetic
patients [6, 22, 23]. Taken together, these ﬁndings suggest
that pancreatic viral infection may occur before and during
onset of clinical diabetes, and that alterations of antiviral
defense in virus-infected pancreatic beta cells may inﬂuence
susceptibility to developing type I diabetes.
Based on our data and a variety of clinical and epi-
demiological observations mentioned earlier, we therefore
suggest that during infection with diabetogenic viruses, the
2 5 AS-RNaseL system in beta cells becomes activated by
IFN-α, while production of dsRNA during virus replication
as well as dsRNA-like molecules during increased insulin
transcription lead to further induction of OAS genes (either
directly or via the TLR3-mediated signaling pathway) and
to activation of 2 5 AS by dsRNA (Figure 9). The markedly
increased activity of the 2 5 AS-RNaseL system would be
detrimental to beta cells, making them more prone to
damage/death during viral infection. Subsequent minor-
but-critical apoptosis of beta cells due to high 2 5 AS
a c t i v i t yw o u l da l l o ws e q u e s t e r e db e t ac e l la n t i g e n st ob e
exposed to the immune system, which (in individuals who10 Experimental Diabetes Research
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Figure 9: Schematic presentation of a model of induction of beta
cell apoptosis during viral infections. Virus infections result in
production of IFN-α and dsRNA. IFN-α induces expression of
2 5 AS though the classical IFN-α signal transduction pathway, and
dsRNAcanleadtoinductionofIFN-α/βandtoexpressionof2 5 AS
via TLR3-mediated signaling pathway. In the presence of dsRNA,
2 5 AS is activated. The 2 5 A oligomers generated by 2 5 AS
stimulate RNaseL-induced apoptosis, which results in subsequent
beta cell autoimmunity. 2 5 AS can also promote cellular apop-
tosis via an enzyme activity-independent pathway. In genetically
predisposed individuals, increased insulin gene expression may
produce dsRNA-like molecules that contribute to enhancement of
the activation and induction of 2 5 AS in beta cells.
are genetically predisposed through, for example, HLA
genes) could trigger an autoimmune response and ultimately
destruction of the pancreatic beta cell mass. Genetic variants
that elevate the constitutive 2 5 AS activity would also facili-
tate this process, such as the OAS1 splice site polymorphism
that we and others have reported to be associated with type
1 diabetes [14, 55], and the insulin VNTR associated with
insulin gene transcription and with type 1 diabetes [45–47].
By contrast, the relatively low activity of the 2 5 AS-RNaseL
system in alpha cells would not lead to any signiﬁcant cell
apoptosis during virus infections. Thus, we speculate that
virus infections cause over-reactivity of the beta cell innate
immune system, which facilitates beta cell apoptosis and
autoimmunity. Measures aimed at regulating the beta cell
antiviral response during the prediabetic phase in genetically
high risk children could help preserve beta cell mass and
thereby prevent or reduce the risk of developing type 1
diabetes.
5. Conclusions
In conclusion, this study showed that following IFN-α
stimulation, increases in 2 5 AS protein level and enzyme
activity were signiﬁcantly higher in beta than in alpha
TC3 cells (P<. 001). It also demonstrated that poly(I:C)
stimulated 2 5 AS enzyme activity in beta TC3 cells but
not in alpha TC3 cells, and that co-transfection of IFN-
α and poly(I:C) induced apoptosis in beta TC3 but not
in alpha TC3 cells. The results suggest that the increased
2 5 AS activity of pancreatic beta cells could render them
particularly vulnerable to apoptosis during virus infection
and to subsequent autoimmune destruction.
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